Market Outlook
The global Avian Influenza Vaccines market size was valued at USD 976.5 million in 2022 and is forecast to a readjusted size of USD 1398.3 million by 2029 with a CAGR of 5.3% during review period.
Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred. Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.
Global Avian Influenza Vaccines key players include Merial, QYH Biotech, DHN, HVRI, etc. Global top four manufacturers hold a share over 80%. China is the largest market, with a share about 45%, followed by Asia (Ex.China), and North America, both have a share about 40 percent. In terms of product, Type H5 is the largest segment, with a share over 70%. And in terms of application, the largest application is Chicken, followed by Duck and Goose, etc.
This report is a detailed and comprehensive analysis for global Avian Influenza Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Avian Influenza Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2018-2029
Global Avian Influenza Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2018-2029
Global Avian Influenza Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2018-2029
Global Avian Influenza Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (M Doses), and ASP (USD/K Doses), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Avian Influenza Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Avian Influenza Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
Merial
QYH Biotech
DHN
HVRI
CEVA
Elanco (Lohmann )
Yebio
Zoetis
FATRO
Kyoto Biken
CAVAC
Ringpu Biology
Vaksindo
ChengDu Tecbond
Sindh Poultry Vaccine Centre
Merck Animal Health
Medion
Avimex Animal Health
JOVAC
Bio-Labs
Segmentation By Type
H5+H7 Avian Influenza Vaccines
H9 Avian Influenza Vaccines
Segmentation By Application
Chicken Avian Influenza Vaccines
Duck & Goose Avian Influenza Vaccines
Other
Segmentation By Region
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the Avian Influenza Vaccines Market in 2025?
The increasing awareness and focus on preventing pandemics, along with ongoing government support and funding, strengthens the market. Advanced vaccine technology, including improved efficiency and effectiveness, also boosts the market’s credibility.
What weaknesses could hinder the growth of the Avian Influenza Vaccines Market in 2025?
Challenges include the high cost of vaccine production and distribution, which may limit access, particularly in developing countries. There is also the issue of limited public awareness about the importance of avian influenza vaccination in some regions.
What opportunities exist for the Avian Influenza Vaccines Market in 2025?
With rising concerns about global health threats, there is significant potential for partnerships and collaborations between governments, healthcare organizations, and vaccine developers. Additionally, growing demand for rapid and more scalable vaccine production presents a notable opportunity.
What threats could affect the Avian Influenza Vaccines Market in 2025?
Economic downturns or shifts in political priorities could impact funding and investment in avian influenza vaccine development. Furthermore, the emergence of new, unpredictable strains of the virus may present challenges to the effectiveness of current vaccines.
Market PESTEL Analysis
What political factors will impact the Avian Influenza Vaccines Market in 2025?
Government policies on public health, funding for vaccine research, and international cooperation in pandemic preparedness will heavily influence the market. Political stability and regulations on vaccine approval and distribution can either foster or hinder market growth.
How will the economic environment affect the Avian Influenza Vaccines Market in 2025?
Economic conditions, such as global recessions or financial crises, could reduce funding for vaccine development and make it harder for developing countries to access vaccines. However, the potential for long-term economic benefits from preventing outbreaks can encourage investment in this sector.
What social factors will shape the Avian Influenza Vaccines Market in 2025?
Increased public awareness about the dangers of avian influenza and the benefits of vaccination will positively impact demand. However, vaccine hesitancy or misinformation could hinder widespread adoption and reduce the overall effectiveness of vaccination campaigns.
How will technological advancements influence the Avian Influenza Vaccines Market in 2025?
Technological innovations in vaccine production, such as faster and more cost-effective manufacturing methods, will help meet global demand. Advancements in genomic research and data analytics will improve the development of vaccines tailored to emerging strains of avian influenza.
What environmental factors could impact the Avian Influenza Vaccines Market in 2025?
Environmental factors, such as changes in climate, can affect the spread of avian influenza by altering migration patterns of birds, potentially leading to more frequent outbreaks. This could increase demand for vaccines but may also present logistical challenges in distribution and storage.
What legal factors need to be considered for the Avian Influenza Vaccines Market in 2025?
Regulatory approval processes for vaccines, intellectual property laws, and international trade regulations will play a significant role. Any changes in these legal frameworks could affect vaccine availability, pricing, and the speed at which new vaccines are introduced to the market.
Market SIPOC Analysis
Who are the suppliers in the Avian Influenza Vaccines Market in 2025?
Suppliers include pharmaceutical companies, biotechnology firms, and research institutions that develop and manufacture the vaccines. Additionally, suppliers of raw materials such as antigens, adjuvants, and delivery systems play a crucial role in vaccine production.
What inputs are required for the Avian Influenza Vaccines Market in 2025?
Inputs include research and development resources, raw materials for vaccine production, regulatory approvals, and funding for manufacturing infrastructure. Skilled workforce and technology for production also serve as essential inputs.
Who are the key process participants in the Avian Influenza Vaccines Market in 2025?
Key process participants include pharmaceutical manufacturers, governmental health agencies, vaccine distributors, healthcare providers, and regulatory bodies that oversee vaccine safety and efficacy.
What outputs are produced in the Avian Influenza Vaccines Market in 2025?
Outputs include the vaccines themselves, regulatory approvals, vaccination programs, and public health campaigns aimed at controlling the spread of avian influenza. The market also produces valuable data on vaccine effectiveness and safety.
Who are the customers in the Avian Influenza Vaccines Market in 2025?
Customers include governments, public health organizations, poultry farmers, and healthcare systems that purchase and distribute vaccines. End-users also include the general public in areas at risk of avian influenza outbreaks.
Market Porter's Five Forces
What is the threat of new entrants in the Avian Influenza Vaccines Market in 2025?
The threat of new entrants is moderate. While the market presents growth opportunities, high entry barriers like regulatory approvals, large capital investments in research and development, and complex vaccine production processes limit the entry of new players.
How intense is the bargaining power of suppliers in the Avian Influenza Vaccines Market in 2025?
Supplier power is relatively high due to the need for specialized raw materials and technology in vaccine production. Limited suppliers for certain components like antigens and adjuvants can give them more leverage in pricing and terms.
How strong is the bargaining power of buyers in the Avian Influenza Vaccines Market in 2025?
Buyer power is moderate. While governments and large organizations typically control purchasing decisions, vaccine prices and availability can affect market access. However, the urgency to prevent avian influenza outbreaks can reduce the negotiating power of individual buyers.
What is the threat of substitute products in the Avian Influenza Vaccines Market in 2025?
The threat of substitutes is low. While antiviral drugs may offer an alternative treatment, vaccines remain the most effective preventive measure against avian influenza, making substitutes less viable in controlling the spread of the disease.
How intense is the competitive rivalry in the Avian Influenza Vaccines Market in 2025?
Competitive rivalry is moderate. The market is driven by a few large pharmaceutical companies with established vaccine portfolios, but there are opportunities for innovation. Intense competition exists in terms of research, regulatory approvals, and distribution capabilities.
Market Upstream Analysis
What are the key raw materials required for the Avian Influenza Vaccines Market in 2025?
Key raw materials include antigens, adjuvants, stabilizers, and excipients used in the formulation of vaccines. Additionally, specialized equipment and technology for vaccine production and storage are essential.
What are the main suppliers involved in the upstream process of the Avian Influenza Vaccines Market in 2025?
Suppliers include biotechnology companies that provide viral strains, antigen manufacturers, and suppliers of production technologies. Additionally, suppliers of raw materials for vaccine stabilizers and packaging play a crucial role in the upstream process.
What challenges do upstream suppliers face in the Avian Influenza Vaccines Market in 2025?
Suppliers face challenges such as fluctuating costs of raw materials, regulatory scrutiny, and the need for highly specialized manufacturing processes. Moreover, the rapid pace of technological advancement requires continuous investment in innovation.
How does the regulatory environment impact upstream activities in the Avian Influenza Vaccines Market in 2025?
The regulatory environment significantly impacts upstream activities, as strict regulations govern the production, safety, and efficacy of vaccine components. Suppliers must meet rigorous standards for quality control, which can result in longer lead times and higher production costs.
What technological advancements are affecting upstream operations in the Avian Influenza Vaccines Market in 2025?
Advancements in genomic research, recombinant DNA technology, and improved manufacturing techniques are transforming upstream operations. These technologies enable faster development and production of more effective vaccines but also require substantial investments in infrastructure and expertise.
Market Midstream Analysis
What key activities take place in the midstream of the Avian Influenza Vaccines Market in 2025?
In the midstream, key activities include vaccine formulation, clinical trials, and regulatory approval processes. It also involves the scaling up of production to meet demand and the packaging of vaccines for distribution.
What are the main challenges faced by midstream players in the Avian Influenza Vaccines Market in 2025?
Midstream players face challenges related to ensuring quality control during mass production, maintaining the cold chain for vaccine distribution, and meeting strict regulatory standards. Delays in clinical trials or approval processes can also significantly impact the market timeline.
How does the regulatory environment impact midstream activities in the Avian Influenza Vaccines Market in 2025?
The regulatory environment plays a significant role in midstream activities, as vaccine production must meet rigorous safety, efficacy, and manufacturing standards. Delays in approvals or changes in regulations can slow down the entire process, affecting both production and distribution.
What role does technology play in the midstream operations of the Avian Influenza Vaccines Market in 2025?
Technology plays a crucial role in midstream operations by enabling efficient vaccine production, advanced data tracking for quality control, and improved testing methods. Automation and AI-driven processes are also helping to streamline production and reduce human error.
How do distribution networks affect midstream activities in the Avian Influenza Vaccines Market in 2025?
Efficient distribution networks are vital in ensuring that vaccines reach the required locations on time. Challenges related to logistics, storage conditions (especially for cold-chain vaccines), and regional distribution infrastructures can impact the timely delivery and availability of vaccines.
Market Downstream Analysis
What key activities take place in the downstream of the Avian Influenza Vaccines Market in 2025?
In the downstream, key activities include the distribution of vaccines to healthcare providers, government agencies, and poultry farms. It also involves vaccination campaigns, public health monitoring, and post-vaccination surveillance to ensure effectiveness.
What are the main challenges faced by downstream players in the Avian Influenza Vaccines Market in 2025?
Downstream players face challenges such as vaccine accessibility in remote regions, managing the cold chain for vaccine storage and transport, and overcoming vaccine hesitancy in certain populations. Additionally, ensuring timely distribution to meet urgent health needs remains a critical challenge.
How does the regulatory environment impact downstream activities in the Avian Influenza Vaccines Market in 2025?
The regulatory environment ensures that vaccines distributed downstream meet safety and efficacy standards. Post-market surveillance and reporting requirements can impact the distribution process, as any adverse events may lead to recalls or further testing, slowing distribution.
What role does technology play in downstream operations of the Avian Influenza Vaccines Market in 2025?
Technology plays a key role in monitoring vaccine distribution, ensuring proper storage conditions, and tracking inventory. Digital platforms for vaccine registration, distribution efficiency, and real-time data collection improve accessibility and manage demand.
How do customer preferences and demand affect downstream activities in the Avian Influenza Vaccines Market in 2025?
Customer demand, especially in regions with high avian influenza risks, drives the need for timely vaccine distribution and availability. Increased awareness and public health campaigns influence vaccine uptake, while regional outbreaks or new threats can spike demand, requiring rapid scaling of distribution.
Chapter 1, to describe Avian Influenza Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Avian Influenza Vaccines, with price, sales, revenue and global market share of Avian Influenza Vaccines from 2018 to 2023.
Chapter 3, the Avian Influenza Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Avian Influenza Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Avian Influenza Vaccines market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Avian Influenza Vaccines.
Chapter 14 and 15, to describe Avian Influenza Vaccines sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Avian Influenza Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Avian Influenza Vaccines Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 H5+H7 Avian Influenza Vaccines
1.3.3 H9 Avian Influenza Vaccines
1.4 Market Analysis by Application
1.4.1 Overview: Global Avian Influenza Vaccines Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Chicken Avian Influenza Vaccines
1.4.3 Duck & Goose Avian Influenza Vaccines
1.4.4 Other
1.5 Global Avian Influenza Vaccines Market Size & Forecast
1.5.1 Global Avian Influenza Vaccines Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Avian Influenza Vaccines Sales Quantity (2018-2029)
1.5.3 Global Avian Influenza Vaccines Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Merial
2.1.1 Merial Details
2.1.2 Merial Major Business
2.1.3 Merial Avian Influenza Vaccines Product and Services
2.1.4 Merial Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merial Recent Developments/Updates
2.2 QYH Biotech
2.2.1 QYH Biotech Details
2.2.2 QYH Biotech Major Business
2.2.3 QYH Biotech Avian Influenza Vaccines Product and Services
2.2.4 QYH Biotech Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 QYH Biotech Recent Developments/Updates
2.3 DHN
2.3.1 DHN Details
2.3.2 DHN Major Business
2.3.3 DHN Avian Influenza Vaccines Product and Services
2.3.4 DHN Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 DHN Recent Developments/Updates
2.4 HVRI
2.4.1 HVRI Details
2.4.2 HVRI Major Business
2.4.3 HVRI Avian Influenza Vaccines Product and Services
2.4.4 HVRI Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 HVRI Recent Developments/Updates
2.5 CEVA
2.5.1 CEVA Details
2.5.2 CEVA Major Business
2.5.3 CEVA Avian Influenza Vaccines Product and Services
2.5.4 CEVA Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 CEVA Recent Developments/Updates
2.6 Elanco (Lohmann )
2.6.1 Elanco (Lohmann ) Details
2.6.2 Elanco (Lohmann ) Major Business
2.6.3 Elanco (Lohmann ) Avian Influenza Vaccines Product and Services
2.6.4 Elanco (Lohmann ) Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Elanco (Lohmann ) Recent Developments/Updates
2.7 Yebio
2.7.1 Yebio Details
2.7.2 Yebio Major Business
2.7.3 Yebio Avian Influenza Vaccines Product and Services
2.7.4 Yebio Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Yebio Recent Developments/Updates
2.8 Zoetis
2.8.1 Zoetis Details
2.8.2 Zoetis Major Business
2.8.3 Zoetis Avian Influenza Vaccines Product and Services
2.8.4 Zoetis Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Zoetis Recent Developments/Updates
2.9 FATRO
2.9.1 FATRO Details
2.9.2 FATRO Major Business
2.9.3 FATRO Avian Influenza Vaccines Product and Services
2.9.4 FATRO Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 FATRO Recent Developments/Updates
2.10 Kyoto Biken
2.10.1 Kyoto Biken Details
2.10.2 Kyoto Biken Major Business
2.10.3 Kyoto Biken Avian Influenza Vaccines Product and Services
2.10.4 Kyoto Biken Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Kyoto Biken Recent Developments/Updates
2.11 CAVAC
2.11.1 CAVAC Details
2.11.2 CAVAC Major Business
2.11.3 CAVAC Avian Influenza Vaccines Product and Services
2.11.4 CAVAC Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 CAVAC Recent Developments/Updates
2.12 Ringpu Biology
2.12.1 Ringpu Biology Details
2.12.2 Ringpu Biology Major Business
2.12.3 Ringpu Biology Avian Influenza Vaccines Product and Services
2.12.4 Ringpu Biology Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Ringpu Biology Recent Developments/Updates
2.13 Vaksindo
2.13.1 Vaksindo Details
2.13.2 Vaksindo Major Business
2.13.3 Vaksindo Avian Influenza Vaccines Product and Services
2.13.4 Vaksindo Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Vaksindo Recent Developments/Updates
2.14 ChengDu Tecbond
2.14.1 ChengDu Tecbond Details
2.14.2 ChengDu Tecbond Major Business
2.14.3 ChengDu Tecbond Avian Influenza Vaccines Product and Services
2.14.4 ChengDu Tecbond Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 ChengDu Tecbond Recent Developments/Updates
2.15 Sindh Poultry Vaccine Centre
2.15.1 Sindh Poultry Vaccine Centre Details
2.15.2 Sindh Poultry Vaccine Centre Major Business
2.15.3 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product and Services
2.15.4 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Sindh Poultry Vaccine Centre Recent Developments/Updates
2.16 Merck Animal Health
2.16.1 Merck Animal Health Details
2.16.2 Merck Animal Health Major Business
2.16.3 Merck Animal Health Avian Influenza Vaccines Product and Services
2.16.4 Merck Animal Health Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Merck Animal Health Recent Developments/Updates
2.17 Medion
2.17.1 Medion Details
2.17.2 Medion Major Business
2.17.3 Medion Avian Influenza Vaccines Product and Services
2.17.4 Medion Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Medion Recent Developments/Updates
2.18 Avimex Animal Health
2.18.1 Avimex Animal Health Details
2.18.2 Avimex Animal Health Major Business
2.18.3 Avimex Animal Health Avian Influenza Vaccines Product and Services
2.18.4 Avimex Animal Health Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Avimex Animal Health Recent Developments/Updates
2.19 JOVAC
2.19.1 JOVAC Details
2.19.2 JOVAC Major Business
2.19.3 JOVAC Avian Influenza Vaccines Product and Services
2.19.4 JOVAC Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 JOVAC Recent Developments/Updates
2.20 Bio-Labs
2.20.1 Bio-Labs Details
2.20.2 Bio-Labs Major Business
2.20.3 Bio-Labs Avian Influenza Vaccines Product and Services
2.20.4 Bio-Labs Avian Influenza Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Bio-Labs Recent Developments/Updates
3 Competitive Environment: Avian Influenza Vaccines by Manufacturer
3.1 Global Avian Influenza Vaccines Sales Quantity by Manufacturer (2018-2023)
3.2 Global Avian Influenza Vaccines Revenue by Manufacturer (2018-2023)
3.3 Global Avian Influenza Vaccines Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Avian Influenza Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Avian Influenza Vaccines Manufacturer Market Share in 2022
3.4.2 Top 6 Avian Influenza Vaccines Manufacturer Market Share in 2022
3.5 Avian Influenza Vaccines Market: Overall Company Footprint Analysis
3.5.1 Avian Influenza Vaccines Market: Region Footprint
3.5.2 Avian Influenza Vaccines Market: Company Product Type Footprint
3.5.3 Avian Influenza Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Avian Influenza Vaccines Market Size by Region
4.1.1 Global Avian Influenza Vaccines Sales Quantity by Region (2018-2029)
4.1.2 Global Avian Influenza Vaccines Consumption Value by Region (2018-2029)
4.1.3 Global Avian Influenza Vaccines Average Price by Region (2018-2029)
4.2 North America Avian Influenza Vaccines Consumption Value (2018-2029)
4.3 Europe Avian Influenza Vaccines Consumption Value (2018-2029)
4.4 Asia-Pacific Avian Influenza Vaccines Consumption Value (2018-2029)
4.5 South America Avian Influenza Vaccines Consumption Value (2018-2029)
4.6 Middle East and Africa Avian Influenza Vaccines Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Avian Influenza Vaccines Sales Quantity by Type (2018-2029)
5.2 Global Avian Influenza Vaccines Consumption Value by Type (2018-2029)
5.3 Global Avian Influenza Vaccines Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Avian Influenza Vaccines Sales Quantity by Application (2018-2029)
6.2 Global Avian Influenza Vaccines Consumption Value by Application (2018-2029)
6.3 Global Avian Influenza Vaccines Average Price by Application (2018-2029)
7 North America
7.1 North America Avian Influenza Vaccines Sales Quantity by Type (2018-2029)
7.2 North America Avian Influenza Vaccines Sales Quantity by Application (2018-2029)
7.3 North America Avian Influenza Vaccines Market Size by Country
7.3.1 North America Avian Influenza Vaccines Sales Quantity by Country (2018-2029)
7.3.2 North America Avian Influenza Vaccines Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Avian Influenza Vaccines Sales Quantity by Type (2018-2029)
8.2 Europe Avian Influenza Vaccines Sales Quantity by Application (2018-2029)
8.3 Europe Avian Influenza Vaccines Market Size by Country
8.3.1 Europe Avian Influenza Vaccines Sales Quantity by Country (2018-2029)
8.3.2 Europe Avian Influenza Vaccines Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Avian Influenza Vaccines Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Avian Influenza Vaccines Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Avian Influenza Vaccines Market Size by Region
9.3.1 Asia-Pacific Avian Influenza Vaccines Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Avian Influenza Vaccines Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Avian Influenza Vaccines Sales Quantity by Type (2018-2029)
10.2 South America Avian Influenza Vaccines Sales Quantity by Application (2018-2029)
10.3 South America Avian Influenza Vaccines Market Size by Country
10.3.1 South America Avian Influenza Vaccines Sales Quantity by Country (2018-2029)
10.3.2 South America Avian Influenza Vaccines Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Avian Influenza Vaccines Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Avian Influenza Vaccines Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Avian Influenza Vaccines Market Size by Country
11.3.1 Middle East & Africa Avian Influenza Vaccines Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Avian Influenza Vaccines Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Avian Influenza Vaccines Market Drivers
12.2 Avian Influenza Vaccines Market Restraints
12.3 Avian Influenza Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Avian Influenza Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Avian Influenza Vaccines
13.3 Avian Influenza Vaccines Production Process
13.4 Avian Influenza Vaccines Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Avian Influenza Vaccines Typical Distributors
14.3 Avian Influenza Vaccines Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Avian Influenza Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Avian Influenza Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merial Basic Information, Manufacturing Base and Competitors
Table 4. Merial Major Business
Table 5. Merial Avian Influenza Vaccines Product and Services
Table 6. Merial Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merial Recent Developments/Updates
Table 8. QYH Biotech Basic Information, Manufacturing Base and Competitors
Table 9. QYH Biotech Major Business
Table 10. QYH Biotech Avian Influenza Vaccines Product and Services
Table 11. QYH Biotech Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. QYH Biotech Recent Developments/Updates
Table 13. DHN Basic Information, Manufacturing Base and Competitors
Table 14. DHN Major Business
Table 15. DHN Avian Influenza Vaccines Product and Services
Table 16. DHN Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. DHN Recent Developments/Updates
Table 18. HVRI Basic Information, Manufacturing Base and Competitors
Table 19. HVRI Major Business
Table 20. HVRI Avian Influenza Vaccines Product and Services
Table 21. HVRI Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. HVRI Recent Developments/Updates
Table 23. CEVA Basic Information, Manufacturing Base and Competitors
Table 24. CEVA Major Business
Table 25. CEVA Avian Influenza Vaccines Product and Services
Table 26. CEVA Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. CEVA Recent Developments/Updates
Table 28. Elanco (Lohmann ) Basic Information, Manufacturing Base and Competitors
Table 29. Elanco (Lohmann ) Major Business
Table 30. Elanco (Lohmann ) Avian Influenza Vaccines Product and Services
Table 31. Elanco (Lohmann ) Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Elanco (Lohmann ) Recent Developments/Updates
Table 33. Yebio Basic Information, Manufacturing Base and Competitors
Table 34. Yebio Major Business
Table 35. Yebio Avian Influenza Vaccines Product and Services
Table 36. Yebio Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Yebio Recent Developments/Updates
Table 38. Zoetis Basic Information, Manufacturing Base and Competitors
Table 39. Zoetis Major Business
Table 40. Zoetis Avian Influenza Vaccines Product and Services
Table 41. Zoetis Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Zoetis Recent Developments/Updates
Table 43. FATRO Basic Information, Manufacturing Base and Competitors
Table 44. FATRO Major Business
Table 45. FATRO Avian Influenza Vaccines Product and Services
Table 46. FATRO Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. FATRO Recent Developments/Updates
Table 48. Kyoto Biken Basic Information, Manufacturing Base and Competitors
Table 49. Kyoto Biken Major Business
Table 50. Kyoto Biken Avian Influenza Vaccines Product and Services
Table 51. Kyoto Biken Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Kyoto Biken Recent Developments/Updates
Table 53. CAVAC Basic Information, Manufacturing Base and Competitors
Table 54. CAVAC Major Business
Table 55. CAVAC Avian Influenza Vaccines Product and Services
Table 56. CAVAC Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. CAVAC Recent Developments/Updates
Table 58. Ringpu Biology Basic Information, Manufacturing Base and Competitors
Table 59. Ringpu Biology Major Business
Table 60. Ringpu Biology Avian Influenza Vaccines Product and Services
Table 61. Ringpu Biology Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Ringpu Biology Recent Developments/Updates
Table 63. Vaksindo Basic Information, Manufacturing Base and Competitors
Table 64. Vaksindo Major Business
Table 65. Vaksindo Avian Influenza Vaccines Product and Services
Table 66. Vaksindo Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Vaksindo Recent Developments/Updates
Table 68. ChengDu Tecbond Basic Information, Manufacturing Base and Competitors
Table 69. ChengDu Tecbond Major Business
Table 70. ChengDu Tecbond Avian Influenza Vaccines Product and Services
Table 71. ChengDu Tecbond Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. ChengDu Tecbond Recent Developments/Updates
Table 73. Sindh Poultry Vaccine Centre Basic Information, Manufacturing Base and Competitors
Table 74. Sindh Poultry Vaccine Centre Major Business
Table 75. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product and Services
Table 76. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Sindh Poultry Vaccine Centre Recent Developments/Updates
Table 78. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 79. Merck Animal Health Major Business
Table 80. Merck Animal Health Avian Influenza Vaccines Product and Services
Table 81. Merck Animal Health Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Merck Animal Health Recent Developments/Updates
Table 83. Medion Basic Information, Manufacturing Base and Competitors
Table 84. Medion Major Business
Table 85. Medion Avian Influenza Vaccines Product and Services
Table 86. Medion Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Medion Recent Developments/Updates
Table 88. Avimex Animal Health Basic Information, Manufacturing Base and Competitors
Table 89. Avimex Animal Health Major Business
Table 90. Avimex Animal Health Avian Influenza Vaccines Product and Services
Table 91. Avimex Animal Health Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Avimex Animal Health Recent Developments/Updates
Table 93. JOVAC Basic Information, Manufacturing Base and Competitors
Table 94. JOVAC Major Business
Table 95. JOVAC Avian Influenza Vaccines Product and Services
Table 96. JOVAC Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. JOVAC Recent Developments/Updates
Table 98. Bio-Labs Basic Information, Manufacturing Base and Competitors
Table 99. Bio-Labs Major Business
Table 100. Bio-Labs Avian Influenza Vaccines Product and Services
Table 101. Bio-Labs Avian Influenza Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 102. Bio-Labs Recent Developments/Updates
Table 103. Global Avian Influenza Vaccines Sales Quantity by Manufacturer (2018-2023) & (M Doses)
Table 104. Global Avian Influenza Vaccines Revenue by Manufacturer (2018-2023) & (USD Million)
Table 105. Global Avian Influenza Vaccines Average Price by Manufacturer (2018-2023) & (USD/K Doses)
Table 106. Market Position of Manufacturers in Avian Influenza Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 107. Head Office and Avian Influenza Vaccines Production Site of Key Manufacturer
Table 108. Avian Influenza Vaccines Market: Company Product Type Footprint
Table 109. Avian Influenza Vaccines Market: Company Product Application Footprint
Table 110. Avian Influenza Vaccines New Market Entrants and Barriers to Market Entry
Table 111. Avian Influenza Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 112. Global Avian Influenza Vaccines Sales Quantity by Region (2018-2023) & (M Doses)
Table 113. Global Avian Influenza Vaccines Sales Quantity by Region (2024-2029) & (M Doses)
Table 114. Global Avian Influenza Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 115. Global Avian Influenza Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 116. Global Avian Influenza Vaccines Average Price by Region (2018-2023) & (USD/K Doses)
Table 117. Global Avian Influenza Vaccines Average Price by Region (2024-2029) & (USD/K Doses)
Table 118. Global Avian Influenza Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 119. Global Avian Influenza Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 120. Global Avian Influenza Vaccines Consumption Value by Type (2018-2023) & (USD Million)
Table 121. Global Avian Influenza Vaccines Consumption Value by Type (2024-2029) & (USD Million)
Table 122. Global Avian Influenza Vaccines Average Price by Type (2018-2023) & (USD/K Doses)
Table 123. Global Avian Influenza Vaccines Average Price by Type (2024-2029) & (USD/K Doses)
Table 124. Global Avian Influenza Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
Table 125. Global Avian Influenza Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
Table 126. Global Avian Influenza Vaccines Consumption Value by Application (2018-2023) & (USD Million)
Table 127. Global Avian Influenza Vaccines Consumption Value by Application (2024-2029) & (USD Million)
Table 128. Global Avian Influenza Vaccines Average Price by Application (2018-2023) & (USD/K Doses)
Table 129. Global Avian Influenza Vaccines Average Price by Application (2024-2029) & (USD/K Doses)
Table 130. North America Avian Influenza Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 131. North America Avian Influenza Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 132. North America Avian Influenza Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
Table 133. North America Avian Influenza Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
Table 134. North America Avian Influenza Vaccines Sales Quantity by Country (2018-2023) & (M Doses)
Table 135. North America Avian Influenza Vaccines Sales Quantity by Country (2024-2029) & (M Doses)
Table 136. North America Avian Influenza Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 137. North America Avian Influenza Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 138. Europe Avian Influenza Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 139. Europe Avian Influenza Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 140. Europe Avian Influenza Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
Table 141. Europe Avian Influenza Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
Table 142. Europe Avian Influenza Vaccines Sales Quantity by Country (2018-2023) & (M Doses)
Table 143. Europe Avian Influenza Vaccines Sales Quantity by Country (2024-2029) & (M Doses)
Table 144. Europe Avian Influenza Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 145. Europe Avian Influenza Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 146. Asia-Pacific Avian Influenza Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 147. Asia-Pacific Avian Influenza Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 148. Asia-Pacific Avian Influenza Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
Table 149. Asia-Pacific Avian Influenza Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
Table 150. Asia-Pacific Avian Influenza Vaccines Sales Quantity by Region (2018-2023) & (M Doses)
Table 151. Asia-Pacific Avian Influenza Vaccines Sales Quantity by Region (2024-2029) & (M Doses)
Table 152. Asia-Pacific Avian Influenza Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 153. Asia-Pacific Avian Influenza Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 154. South America Avian Influenza Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 155. South America Avian Influenza Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 156. South America Avian Influenza Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
Table 157. South America Avian Influenza Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
Table 158. South America Avian Influenza Vaccines Sales Quantity by Country (2018-2023) & (M Doses)
Table 159. South America Avian Influenza Vaccines Sales Quantity by Country (2024-2029) & (M Doses)
Table 160. South America Avian Influenza Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 161. South America Avian Influenza Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 162. Middle East & Africa Avian Influenza Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 163. Middle East & Africa Avian Influenza Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 164. Middle East & Africa Avian Influenza Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
Table 165. Middle East & Africa Avian Influenza Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
Table 166. Middle East & Africa Avian Influenza Vaccines Sales Quantity by Region (2018-2023) & (M Doses)
Table 167. Middle East & Africa Avian Influenza Vaccines Sales Quantity by Region (2024-2029) & (M Doses)
Table 168. Middle East & Africa Avian Influenza Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 169. Middle East & Africa Avian Influenza Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 170. Avian Influenza Vaccines Raw Material
Table 171. Key Manufacturers of Avian Influenza Vaccines Raw Materials
Table 172. Avian Influenza Vaccines Typical Distributors
Table 173. Avian Influenza Vaccines Typical Customers
List of Figures
Figure 1. Avian Influenza Vaccines Picture
Figure 2. Global Avian Influenza Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Avian Influenza Vaccines Consumption Value Market Share by Type in 2022
Figure 4. H5+H7 Avian Influenza Vaccines Examples
Figure 5. H9 Avian Influenza Vaccines Examples
Figure 6. Global Avian Influenza Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Avian Influenza Vaccines Consumption Value Market Share by Application in 2022
Figure 8. Chicken Avian Influenza Vaccines Examples
Figure 9. Duck & Goose Avian Influenza Vaccines Examples
Figure 10. Other Examples
Figure 11. Global Avian Influenza Vaccines Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Avian Influenza Vaccines Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Avian Influenza Vaccines Sales Quantity (2018-2029) & (M Doses)
Figure 14. Global Avian Influenza Vaccines Average Price (2018-2029) & (USD/K Doses)
Figure 15. Global Avian Influenza Vaccines Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Avian Influenza Vaccines Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Avian Influenza Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Avian Influenza Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Avian Influenza Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Avian Influenza Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Avian Influenza Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Avian Influenza Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Avian Influenza Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Avian Influenza Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Avian Influenza Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Avian Influenza Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Avian Influenza Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Avian Influenza Vaccines Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Avian Influenza Vaccines Average Price by Type (2018-2029) & (USD/K Doses)
Figure 30. Global Avian Influenza Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Avian Influenza Vaccines Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Avian Influenza Vaccines Average Price by Application (2018-2029) & (USD/K Doses)
Figure 33. North America Avian Influenza Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Avian Influenza Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Avian Influenza Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Avian Influenza Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Avian Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Avian Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Avian Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Avian Influenza Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Avian Influenza Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Avian Influenza Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Avian Influenza Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Avian Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Avian Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Avian Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Avian Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Avian Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Avian Influenza Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Avian Influenza Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Avian Influenza Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Avian Influenza Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 53. China Avian Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Avian Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Avian Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Avian Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Avian Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Avian Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Avian Influenza Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Avian Influenza Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Avian Influenza Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Avian Influenza Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Avian Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Avian Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Avian Influenza Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Avian Influenza Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Avian Influenza Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Avian Influenza Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Avian Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Avian Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Avian Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Avian Influenza Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Avian Influenza Vaccines Market Drivers
Figure 74. Avian Influenza Vaccines Market Restraints
Figure 75. Avian Influenza Vaccines Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Avian Influenza Vaccines in 2022
Figure 78. Manufacturing Process Analysis of Avian Influenza Vaccines
Figure 79. Avian Influenza Vaccines Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
